Zenith Drugs Ltd

Pharmaceuticals

Offer Period :

19th to 2nd Feb 2024

Zenith Drugs Limited, founded in 2000, focuses on producing and distributing high-quality, affordable pharmaceuticals, adhering to WHO-GMP standards and holding ISO 9001:2015 certification. Their product line includes ORS Powder, Liquid Orals, Ointments, Liquid Externals, and Capsules,Read more... with over 600 FDA-approved products. They're establishing a new manufacturing facility in Indore, MP, and offer third-party manufacturing services. Employing 89 individuals as of March 31, 2023.Read less

Zenith Drugs Ltd IPO Details

IPO Date 19th to 2nd Feb 2024 Minimum Investment ₹126400 / 1 Lots
Listing Date 2024-02-27 Maximum Investment ₹126400 / 1 Lots
Face Value ₹10 per share Total Issue Size ₹40.68 Crores
Price ₹79 to ₹79 per share Fresh Issue ₹40.68 Crores
Lot Size 1 Lots (1600 Shares) Offer For Sale ₹ 0
Listing At NSE-SME Retail Discount ₹ 0
Employee Discount ₹ 0    
IPO Date 19th to 2nd Feb 2024
Listing Date 2024-02-27
Face Value ₹10 per share
Price ₹79 to ₹79 per share
Lot Size 1 Lots (1600 Shares)
Listing At NSE-SME
Employee Discount ₹0 Crores
Minimum Investment ₹126400 / 1 Lots
Maximum Investment ₹126400 / 1 Lots
Total Issue Size ₹40.68 Crores
Fresh Issue ₹40.68 Crores
Offer For Sale
Retail Discount ₹ 0

Tentative Timeline

Important dates for allocation and IPO listing.

19th Feb

IPO Starts

22nd Feb

IPO Ends

23rd Feb

Allotment Date

26th Feb

Initiation of Refund

26th Feb

Credit of Shares to Demat Account

27th Feb

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 91.58 64.09
Public Group 8.42 35.91

Zenith Drugs Ltd IPO Reservation

QIB Shares Offered 2147200(41.7%)
NII (HNI) Shares Offered 644800(12.52%)
Retail Shares Offered 1504000(29.21%)
Anchor Investor Shares Offered 0(0%)
Total Shares Offered 5148800
Total Shares With Anchor Investor 5148800

IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)---
Retail (Max)---
S-HNI (Min)---
S-HNI (Max)---

Zenith Drugs Ltd IPO Registrar

Bigshare Services Pvt Ltd
Phone Number +91 - 22 - 6263 8200;
Email Id ipo@bigshareonline.com
Our Website www.bigshareonline.com

Zenith Drugs Ltd IPO Lead Manager

1. Gretex Corporate Services Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Zenith Drugs Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed

Strength of Zenith Drugs Ltd

1. Experienced Promoters and Management Team.

2. Cost Efficiency.

3. Formulation & Development.

4. Regulatory Compliance.

5. Global Reach.

6. Product Portfolio.

7. Supply Chain Efficiency.

8. Scalable Business Model.

9. Strong sales, marketing, and distribution capabilities.

Risks Involved

1. There are outstanding legal proceedings involving the Company, Promoters and Directors. Any adverse decision in such proceeding may have a material adverse effect on its business, results of operations and financial condition.

2. Any manufacturing or quality control problems may disrupt its business operations, damage the company reputation for high quality production and expose it to potential litigation or other liabilities, which would negatively impact its business, prospects, cash flows, results of operations and financial condition.

3. The company highly depends on its major raw materials and a few key suppliers who help it procure the same. the Company has not entered into long-term agreements with its suppliers for supply of raw materials. In the event the company is unable to procure adequate amounts of raw materials, at competitive prices its business, results of operations and financial condition may be adversely affected.

4. The company conducts its business activities on a purchase order basis and therefore, has not entered into long-term agreements with its customers except government contracts.

5. Its business activities are exposed to fluctuations in the prices of raw materials.

6. If the company cannot respond adequately to the increased competition its expect to face, the company will lose market share and its profits will decline, which will adversely affect its business, results of operations and financial condition.

7. The company is required to obtain, renew or maintain certain statutory and regulatory permits and approvals required to operate its business and if the company fail to do so in a timely manner or at all and its business, financial conditions, results of operations, and cash flows may be adversely affected.

8. The Company is reliant on the demand from the pharmaceutical industry for a significant portion of its revenue. Any downturn in the pharmaceutical industry or an inability to increase or effectively manage its sales could have an adverse impact on the Company's business and results of operations.

9. Continued operations of its manufacturing facility are critical to the company business and any disruption in the operation of its manufacturing facility may have a material adverse effect on its business, results of operations and financial condition.

10. Majority of its revenue is dependent on two products i.e., ORS Powder and Liquid Orals, if the company is unable to anticipate or adapt to evolving upgradation of products or inability to ensure product quality or reduction in the demand of such products may adversely impact its revenue from operations and growth prospects.

Why should you invest in

-

Financials

Particulars For the financial year ending (in ₹ million)
  2023 2022
Total Assets 97.94 68.58
Total Liabilities 97.94 68.58
Total Expenses 108.49 88.26
Total Revenue 
115.7 92.67
Profit After Tax 5.15 3.14
EBITDA 10.85 7.84
Adjusted EBITDA 0 0

Zenith Drugs Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2024-02-27 92356 ZENITHDRUG
INE0QWN01013
₹79 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹79 ₹79
Open ₹0 ₹110
Low ₹0 ₹104.5
High ₹0 ₹114.5
Low ₹0 ₹104.5

Frequently Asked Questions

What is Zenith Drugs Ltd IPO?

Answer Field

Zenith Drugs Ltd IPO is a SME IPO of 51,48,800 equity shares of a face value of ₹10 aggregating up to ₹40.68 Crores. The issue is priced at ₹79 to ₹79 per share. The minimum order quantity is 1600 Shares. The IPO opens on February 19, 2024, and closes on February 22, 2024. Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE-SME.

When Zenith Drugs Ltd IPO will open?

Answer Field

The Zenith Drugs Ltd IPO opens on February 19, 2024 and closes on February 22, 2024.

What is the lot size of Zenith Drugs Ltd?

Answer Field

Zenith Drugs Ltd lot size is 1600 shares, and the minimum amount required is ₹1,26,400.

How to apply for Zenith Drugs Ltd IPO?

Answer Field

You can apply in Zenith Drugs Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Zenith Drugs Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Zenith Drugs Ltd IPO will be done on February 23, 2024, and the allotted shares will be credited to your demat account by February 26, 2024.

When is Zenith Drugs Ltd IPO listing date?

Answer Field

The Zenith Drugs Ltd listing date is February 27, 2024.

Who is the registrar of Zenith Drugs Ltd IPO?

Answer Field

The registrar of Zenith Drugs Ltd IPO is Bigshare Services Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Gretex Corporate Services Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Zenith Drugs Ltd IPO?

Answer Field

The fresh issue size is ₹40.68 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Zenith Drugs Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 1600 shares and ₹1,26,400 amount.

How can I approve the UPI mandate request for Zenith Drugs Ltd IPO?

Answer Field

To apply for Zenith Drugs Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Zenith Drugs Ltd?

Answer Field

The price of each Zenith Drugs Ltd share will be ranging in between ₹79 to ₹79 per share.

What is the cut-off time for the UPI mandate for Zenith Drugs Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, February 22, 2024.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • TROM INDUSTRIES LIMITEDSME IPO

  • Bidding Dates

    25th Jul 2024 - 7th Jul 2024

  • Price Range

    ₹110 - 115

  • IPO Size

    ₹31,37,00,000

  • Apply Now
  • ESPRIT STONES LIMITEDSME IPO

  • Bidding Dates

    26th Jul 2024 - 7th Jul 2024

  • Price Range

    ₹82 - 87

  • IPO Size

    ₹50,42,00,000

  • Apply Now
  • ASHAPURA LOGISTICS LIMITEDSME IPO Early Access

  • Bidding Dates

    30th Jul 2024 - 8th Aug 2024

  • Price Range

    ₹136 - 144

  • IPO Size

    ₹52,66,00,000

  • Apply Now
  • BULKCORP INTERNATIONAL LIMITEDSME IPO Early Access

  • Bidding Dates

    30th Jul 2024 - 8th Aug 2024

  • Price Range

    ₹100 - 105

  • IPO Size

    ₹20,77,00,000

  • Apply Now
  • RAJPUTANA INDUSTRIES LIMITEDSME IPO Early Access

  • Bidding Dates

    30th Jul 2024 - 8th Aug 2024

  • Price Range

    ₹36 - 38

  • IPO Size

    ₹23,88,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • SANSTAR LIMITEDMainboard IPO

  • Bidding Dates

    19th Jul 2024 - 7th Jul 2024

  • Price Range

    ₹90 - 95

  • IPO Size

    ₹5,10,15,00,000

  • Invest Now
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • SAR TELEVENTURE LIMITEDSME IPO

  • Issue Price

    55.00

  • Listing Day Close

    110.25

  • Listing Day (Gain/Loss)

    100.00

  • SANSTAR LIMITEDMainboard IPO

  • Issue Price

    95.00

  • Listing Day Close

    115.09

  • Listing Day (Gain/Loss)

    21.05

  • KATARIA INDUSTRIES LIMITEDSME IPO

  • Issue Price

    96.00

  • Listing Day Close

    191.50

  • Listing Day (Gain/Loss)

    100.00

  • MACOBS TECHNOLOGIES LIMITEDSME IPO

  • Issue Price

    75.00

  • Listing Day Close

    100.80

  • Listing Day (Gain/Loss)

    34.67

  • TUNWAL EMOTORS LIMITEDSME IPO

  • Issue Price

    59.00

  • Listing Day Close

    60.80

  • Listing Day (Gain/Loss)

    3.39

  • PRIZOR VIZTECH LIMITEDSME IPO

  • Issue Price

    87.00

  • Listing Day Close

    173.55

  • Listing Day (Gain/Loss)

    100.00

  • THREE M PAPER BOARDS LIMITEDSME IPO

  • Issue Price

    69.00

  • Listing Day Close

    79.80

  • Listing Day (Gain/Loss)

    15.94

  • SATI POLY PLAST LIMITEDSME IPO

  • Issue Price

    130.00

  • Listing Day Close

    259.35

  • Listing Day (Gain/Loss)

    99.23

  • AELEA COMMODITIES LIMITEDSME IPO

  • Issue Price

    95.00

  • Listing Day Close

    173.25

  • Listing Day (Gain/Loss)

    82.11

  • SAHAJ SOLAR LIMITEDSME IPO

  • Issue Price

    180.00

  • Listing Day Close

    359.10

  • Listing Day (Gain/Loss)

    99.44

  • EFFWA INFRA AND RESEARCH LIMITEDSME IPO

  • Issue Price

    82.00

  • Listing Day Close

    163.55

  • Listing Day (Gain/Loss)

    100.00

  • GANESH GREEN BHARAT LIMITEDSME IPO

  • Issue Price

    190.00

  • Listing Day Close

    379.05

  • Listing Day (Gain/Loss)

    99.47

  • AMBEY LABORATORIES LIMITEDSME IPO

  • Issue Price

    68.00

  • Listing Day Close

    89.25

  • Listing Day (Gain/Loss)

    30.88

  • BANSAL WIRE INDUSTRIES LIMITEDMainboard IPO

  • Issue Price

    256.00

  • Listing Day Close

    350.30

  • Listing Day (Gain/Loss)

    36.72

  • EMCURE PHARMACEUTICALS LIMITEDMainboard IPO

  • Issue Price

    1008.00

  • Listing Day Close

    1358.85

  • Listing Day (Gain/Loss)

    34.82

  • NEPHRO CARE INDIA LIMITEDSME IPO

  • Issue Price

    90.00

  • Listing Day Close

    179.55

  • Listing Day (Gain/Loss)

    100.00

  • DIENSTEN TECH LIMITEDSME IPO

  • Issue Price

    100.00

  • Listing Day Close

    252.00

  • Listing Day (Gain/Loss)

    152.00

  • VRAJ IRON AND STEEL LIMITEDMainboard IPO

  • Issue Price

    207.00

  • Listing Day Close

    251.95

  • Listing Day (Gain/Loss)

    21.74

  • AKIKO GLOBAL SERVICES LIMITEDSME IPO

  • Issue Price

    77.00

  • Listing Day Close

    93.35

  • Listing Day (Gain/Loss)

    20.78

  • PETRO CARBON AND CHEMICALS LIMITEDSME IPO

  • Issue Price

    171.00

  • Listing Day Close

    315.00

  • Listing Day (Gain/Loss)

    84.21

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text